OZ Intelligent Newborn Health
A baby is born. A newborn screening helps protect, improve or save a life. A routine well-baby visit provides peace of mind. A little girl grows - and so does her medical history. OZ Systems brings it all together - making it interoperable, meaningful and impactful.
Developed to give healthcare providers and public health departments the integrated tool needed to efficiently Screen, Track, Analyze and Report data, OZ STAR™ tackles the very real challenge of a disconnected, siloed newborn screening process.
The fully integrated technology platform combines previously disparate tasks, allowing clinical staff to capture point of care screening results for early hearing detection and intervention (EHDI) and critical congenital heart disease (CCHD). The platform also merges data from the baby’s hospital admission and birth record and any additional newborn screening data to create a fully interoperable record that can be tracked and analyzed within...
Smooth care delivery, improved outcomes and a profoundly better start in life: that is why OZ BabyBundle™ was born. Using the newly-added screening for critical congenital heart defects (CCHD) as a catalyst, the first-of-its-kind integrated software solution captures pulse oximetry screening results for Critical Congenital Heart Defects (CCHD) directly from the device. OZ BabyBundle™ features a medical-grade tablet that connects to specific motion-tolerant pulse oximeters approved for neonatal use. The system provides software-based...
In little more than a decade, there has been monumental progress in early detection and early intervention services for these babies. Each year in the U.S. alone, more than 12,000 babies are born with a hearing loss. Undetected or late detection of hearing loss can affect a child's ability to develop communication, social and language skills.
Today, nearly 98 percent of newborns are screened for hearing loss. Since the inception of this screening, OZ Systems has been on the front lines of a public health push toward better, more comprehensive data collection and data management to support improved follow up and clinical outcomes.
OZ Genetic + Metabolic Screening Solutions
More than 12,000 infants a year are affected by diseases and disorders that are commonly screened for in the newborn period. Better known as the heel-stick test, these screenings are usually performed when a baby is 24-48 hours old. Early detection, treatment and management of these conditions can help prevent intellectual disability, physical disability, or even early death.
OZ Systems’ web-based module provides a comprehensive record of a child’s newborn bloodspot screening beginning with the capture of details from the specimen card and screening results, to connecting the infant to timely and critical short term follow-up care and services.
OZ Birth Defect Screening Solutions
Birth defects affect 1 in every 33. Early intervention and treatment are critical to improved outcomes and establishing a profoundly better start in life for these children.
The most prevalent birth defect is congenital heart disease - or heart defects, which are responsible for more than 30 percent of all birth defect related deaths in infancy. OZ Systems has been at the forefront of this newly recommended point of care screening for all newborns – crafting a first-of-its-kind nurse-designed workflow system to support screening for heart defects (CCHD).